Stopped: Business decision to terminate the study early. Primary endpoint will not be assessed.
United States1,823 participantsStarted 2022-04-28
Plain-language summary
The primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening rates and time adherent to CRC guidelines. The results will not be posted because the study terminated early and the primary endpoint was not analyzed.
Who can participate
Age range45 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Participant is 45 to 70 years of age, inclusive.
✓. Participant presents for a primary care appointment.
✓. Participant understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information (PHI) to the study Investigator.
✓. Participant has never been screened for CRC.
Exclusion criteria
✕. Participant has symptoms or signs that require immediate, or near-term referral for diagnostic or therapeutic colonoscopy.
✕. Participant is due for CRC screening within three months and is already scheduled for colonoscopy.
✕. Participant has a personal history of CRC or colonic adenomatous or sessile serrated polyps.
✕. Participant has a personal history of inflammatory bowel disease.
✕. Participant has a family history of CRC in at least one first- or second-degree relative diagnosed prior to age 60 and/or at least 2 first-degree relatives diagnosed with CRC at any age.
✕. Participant has a personal diagnosis or family history of any of the following conditions:
✕. Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP and Gardner's syndrome),